LifeRx.md Expands Clinical Services to Include NAD+ and Methylene Blue; Confirms Leadership in GLP and GIP Metabolic Care
LOS ANGELES, CA / CorporatePRwire / August 29, 2025 / LifeRx.md today announced a definitive expansion of its clinical services. After establishing a permanent leadership position in GLP and GIP metabolic care, LifeRx.md will introduce clinician-supervised NAD+ and methylene blue therapies to its treatment menu, effective September 2025. This expansion is a permanent enhancement to LifeRx.md’s […]